Panbela Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Panbela Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Panbela Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $103K, a 42.8% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $823K, a 24.4% decline from 2022.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.09M, a 15.5% decline from 2021.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.29M, a 6.81% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $823K -$265K -24.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $1.09M -$199K -15.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $1.29M +$82K +6.81% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $1.21M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2018 $263K -$232K -46.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-22
2017 $495K -$62K -11.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $557K +$487K +696% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 $70K +$44K +169% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $26K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.